Skip to main content

Table 1 Demographic data of patients with osteoarthritis and those with rheumatoid arthritis

From: Potential role and mechanism of IFN-gamma inducible protein-10 on receptor activator of nuclear factor kappa-B ligand (RANKL) expression in rheumatoid arthritis

 

Osteoarthritis

(n= 11)

Rheumatoid arthritis

(n= 18)

Age in years, mean ± SD

67.20 ± 7.35

57.17 ± 9.51

Females/Males

10:1

17:1

Duration of disease in months, mean ± SD

79.64 ± 62.66

114.85 ± 49.54

Treatment, number (percentage)

  

   Prednisolone

 

15 (83%)

   DMARDs

 

18 (100%)

   Methotrexate

 

16 (89%)

   Sulfasalazine

 

2 (11%)

   Hydroxychloroguine

 

7 (39%)

   Leflunomide

 

5 (28%)

   Azathioprine

 

3 (17%)

  1. DMARD, disease-modifying antirheumatic drug; SD, standard deviation.